Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 25 April 2023 30 April 2024 30 April 2024 14825694 Dr Jill Powell iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14825694 2023-04-24 14825694 2024-04-30 14825694 2023-04-25 2024-04-30 14825694 frs-core:CurrentFinancialInstruments 2024-04-30 14825694 frs-core:Non-currentFinancialInstruments 2024-04-30 14825694 frs-bus:PrivateLimitedCompanyLtd 2023-04-25 2024-04-30 14825694 frs-bus:FilletedAccounts 2023-04-25 2024-04-30 14825694 frs-bus:Micro-entities 2023-04-25 2024-04-30 14825694 frs-bus:AuditExempt-NoAccountantsReport 2023-04-25 2024-04-30 14825694 frs-bus:Director1 2023-04-25 2024-04-30
Registered number: 14825694
Scitype Writing Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2024
Balance Sheet
Registered number: 14825694
2024
£
Fixed assets 217
Current assets 13,781
Prepayments and accrued income 89
Creditors: Amounts Falling Due Within One Year (8,172 )
NET CURRENT ASSETS 5,698
TOTAL ASSETS LESS CURRENT LIABILITIES 5,915
Creditors: Amounts Falling After More Than One Year (77 )
NET ASSETS 5,838
CAPITAL AND RESERVES 5,838

Notes

1. General Information
Scitype Writing Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14825694 . The registered office is Belmont Suite, Paragon Business Park, Chorley New Road, Horwich, Bolton, BL6 6HG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Jill Powell
Director
18/10/2024